Sports Med Health Sci 润色咨询

Sports Medicine and Health Science

出版年份:2019 年文章数:暂无数据 投稿命中率: 开通期刊会员,数据随心看

出版周期:季刊 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2024-02-28 Dazhi3919 来自四川省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:运动医学
    经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。
    期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。
    目前的接受率大概是22.5%。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2022-12-31 ms4000001867849581 来自山东省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:运动医学;康复医学;运动干预
    经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2023-01-04 ms9000001425203091 来自山东省

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:运动医学;康复医学;运动干预
    经验分享:命中率比较低

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2023-01-04 ms9000001425203091 来自山东省

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:会要求有个简写表

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2023-01-04 ms9000001425203091 来自山东省

    审稿速度:2.0 | 投稿命中率:5.0
    偏重的研究方向:运动医学;康复医学;运动干预
    经验分享:健康科学的也可以接收

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2023-01-04 ms9000001425203091 来自山东省

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:挺难的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2023-01-04 ms4000001867849581 来自山东省

    审稿速度:3.0 | 投稿命中率:5.0
    偏重的研究方向:运动干预
    经验分享:第二篇体力活动干预的拒稿了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2023-01-04 ms9000001425203091 来自山东省

    审稿速度:2.0 | 投稿命中率:5.0
    偏重的研究方向:运动医学
    经验分享:初审两个月,拒稿了,没有这上面说的一样容易

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2022-09-10 ms4000001867849581

    有投过这家期刊的吗,难不难#期刊论坛##学习#

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2189907, encodeId=c804218990e91, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:运动医学<br>经验分享:《Sports Medicine and Health Science》期刊是“中国科技期刊卓越行动计划”高起点新刊;“体育领域高质量科技期刊分级目录”T2级期刊;已被ESCI、PubMed、Scopus、Embase、EBSCO、CAS、DOAJ等重要国际数据库收录。<br>期刊2023年的Citescore=5.7在Q1区,2024年6月将会有第一个影响因子。<br>目前的接受率大概是22.5%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09b101102, createdName=Dazhi3919, createdTime=Wed Feb 28 16:14:03 CST 2024, time=2024-02-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2108281, encodeId=dbad21082812e, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:明年就有影响因子了,据这家期刊公众号新消息:在中国科学技术信息研究所科技期刊世界影响力指数(WJCI)报告中,按照WJCI排名,位列全球97种“运动科学”类刊物的第33位,属于Q2区;按照影响因子进行排名,位居全球97种期刊的第10位,属于Q1区。另外,2022年6月SMHS获得了Scopus数据库的第一个CiteScore引用分,3.5分,在 “Health Professions: Physical Therapy, Sports Therapy and Rehabilitation” 和 “Medicine: Orthopedics and Sports Medicine” 两个学科类别中,均位于Q2区。根据实时更新的数据,2022年12月 CiteScore 达到了5.7。 总之后面肯定会越来越难中,如果中科院分区再收录就更难了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 31 14:04:47 CST 2022, time=2022-12-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108764, encodeId=8a1f2108e64a0, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:命中率比较低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:49 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108763, encodeId=f5e22108e636a, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:会要求有个简写表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:09:17 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108761, encodeId=72472108e6117, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:健康科学的也可以接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:08:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108760, encodeId=12752108e6024, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 12:07:37 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108758, encodeId=50012108e5887, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:运动干预<br>经验分享:第二篇体力活动干预的拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Wed Jan 04 12:05:31 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108757, encodeId=ab6d2108e57e1, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:运动医学<br>经验分享:初审两个月,拒稿了,没有这上面说的一样容易 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=508c8498025, createdName=ms9000001425203091, createdTime=Wed Jan 04 11:58:00 CST 2023, time=2023-01-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248237, encodeId=abc5124823eb5, content=有投过这家期刊的吗,难不难<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Sep 10 05:06:28 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106504, encodeId=4ee5210650432, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:运动医学;康复医学;运动干预<br>经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 <a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abb56415335, createdName=ms4000001867849581, createdTime=Sat Dec 17 20:38:18 CST 2022, time=2022-12-17, status=1, ipAttribution=山东省)]
    2022-12-17 ms4000001867849581 来自山东省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:运动医学;康复医学;运动干预
    经验分享:硕士期间刚中了一篇,官网说接受率是40%,我这篇审了前后五个多月,返修时收到审稿人2000单词的意见,改了一半反驳一半,回复写了4000单词,最后处理了一些细节问题就接收了,最近刚OA见刊。 主要来说审稿周期太长了,如果为了毕业不建议投,最近是cite score二区,中科院还未收录,希望越办越好吧,毕竟不要版面费还是挺吸引人的。 #期刊论坛#

    0

共17条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分